Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 4
2001 1
2003 1
2011 1
2018 1
2021 1
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapy.
Bartneck J, Hartmann AK, Stein L, Arnold-Schild D, Klein M, Stassen M, Marini F, Pielenhofer J, Meiser SL, Langguth P, Mack M, Muth S, Probst HC, Schild H, Radsak MP. Bartneck J, et al. Among authors: arnold schild d. Front Immunol. 2023 Oct 2;14:1267866. doi: 10.3389/fimmu.2023.1267866. eCollection 2023. Front Immunol. 2023. PMID: 37849753 Free PMC article.
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
Hartmann AK, Bartneck J, Pielenhofer J, Meiser SL, Arnold-Schild D, Klein M, Stassen M, Schild H, Muth S, Probst HC, Langguth P, Grabbe S, Radsak MP. Hartmann AK, et al. Among authors: arnold schild d. Front Immunol. 2023 Sep 1;14:1238861. doi: 10.3389/fimmu.2023.1238861. eCollection 2023. Front Immunol. 2023. PMID: 37727790 Free PMC article.
Stress proteins and immunity mediated by cytotoxic T lymphocytes.
Schild H, Arnold-Schild D, Lammert E, Rammensee HG. Schild H, et al. Among authors: arnold schild d. Curr Opin Immunol. 1999 Feb;11(1):109-13. doi: 10.1016/s0952-7915(99)80019-3. Curr Opin Immunol. 1999. PMID: 10047535 Review.
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors.
Stickdorn J, Stein L, Arnold-Schild D, Hahlbrock J, Medina-Montano C, Bartneck J, Ziß T, Montermann E, Kappel C, Hobernik D, Haist M, Yurugi H, Raabe M, Best A, Rajalingam K, Radsak MP, David SA, Koynov K, Bros M, Grabbe S, Schild H, Nuhn L. Stickdorn J, et al. Among authors: arnold schild d. ACS Nano. 2022 Mar 22;16(3):4426-4443. doi: 10.1021/acsnano.1c10709. Epub 2022 Feb 1. ACS Nano. 2022. PMID: 35103463 Free PMC article.
ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression.
Riegel K, Yurugi H, Schlöder J, Jonuleit H, Kaulich M, Kirschner F, Arnold-Schild D, Tenzer S, Schild H, Rajalingam K. Riegel K, et al. Among authors: arnold schild d. Cell Death Dis. 2021 Oct 20;12(11):969. doi: 10.1038/s41419-021-04257-8. Cell Death Dis. 2021. PMID: 34671021 Free PMC article.
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages.
Bohn T, Rapp S, Luther N, Klein M, Bruehl TJ, Kojima N, Aranda Lopez P, Hahlbrock J, Muth S, Endo S, Pektor S, Brand A, Renner K, Popp V, Gerlach K, Vogel D, Lueckel C, Arnold-Schild D, Pouyssegur J, Kreutz M, Huber M, Koenig J, Weigmann B, Probst HC, von Stebut E, Becker C, Schild H, Schmitt E, Bopp T. Bohn T, et al. Among authors: arnold schild d. Nat Immunol. 2018 Dec;19(12):1319-1329. doi: 10.1038/s41590-018-0226-8. Epub 2018 Nov 5. Nat Immunol. 2018. PMID: 30397348
Modulation of cellular transcriptome and proteome composition by azidohomoalanine-implications on click chemistry-based secretome analysis.
Kirschner F, Arnold-Schild D, Leps C, Łącki MK, Klein M, Chen Y, Ludt A, Marini F, Kücük C, Stein L, Distler U, Sielaff M, Michna T, Riegel K, Rajalingam K, Bopp T, Tenzer S, Schild H. Kirschner F, et al. Among authors: arnold schild d. J Mol Med (Berl). 2023 Jul;101(7):855-867. doi: 10.1007/s00109-023-02333-4. Epub 2023 May 26. J Mol Med (Berl). 2023. PMID: 37231147 Free PMC article.
Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS2Rescore with MS2PIP timsTOF fragmentation prediction model.
Gomez-Zepeda D, Arnold-Schild D, Beyrle J, Declercq A, Gabriels R, Kumm E, Preikschat A, Łącki MK, Hirschler A, Rijal JB, Carapito C, Martens L, Distler U, Schild H, Tenzer S. Gomez-Zepeda D, et al. Among authors: arnold schild d. Nat Commun. 2024 Mar 13;15(1):2288. doi: 10.1038/s41467-024-46380-y. Nat Commun. 2024. PMID: 38480730 Free PMC article.
16 results